| Engaging innate immunity in HIV-1 cure strategies NL Board, M Moskovljevic, F Wu, RF Siliciano, JD Siliciano Nature Reviews Immunology 22 (8), 499-512, 2022 | 49 | 2022 |
| TCR-mimic bispecific antibodies to target the HIV-1 reservoir S Sengupta, NL Board, F Wu, M Moskovljevic, J Douglass, J Zhang, ... Proceedings of the National Academy of Sciences 119 (15), e2123406119, 2022 | 11 | 2022 |
| Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine Z Tariq, N Board, A Eftimiades, R Ibrahim SAGE Open Medical Case Reports 7, 2050313X19847804, 2019 | 10 | 2019 |
| Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition WH Chen, JH Kim, W Bu, NL Board, Y Tsybovsky, Y Wang, A Hostal, ... Immunity 55 (11), 2135-2148. e6, 2022 | 7 | 2022 |
| B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection CO Ogega, NE Skinner, AI Flyak, KE Clark, NL Board, PJ Bjorkman, ... PloS pathogens 18 (1), e1010179, 2022 | 6 | 2022 |
| A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design S Sengupta, J Zhang, MC Reed, J Yu, A Kim, TN Boronina, NL Board, ... Journal of Experimental Medicine 220 (7), 2023 | 4 | 2023 |
| Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells NL Board, Z Yuan, F Wu, M Moskovljevic, M Ravi, S Sengupta, SS Mun, ... Nature Immunology, 1-9, 2024 | 3 | 2024 |
| Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells W Bu, A Kumar, NL Board, JH Kim, K Dowdell, S Zhang, Y Lei, A Hostal, ... Immunity 57 (3), 559-573. e6, 2024 | | 2024 |
| Cognate Antigen Engagement Induces HIV-1 Expression In CD4+ T Cells From People On Long-Term ART M Moskovjlevic, F Dragoni, NL Board, F Wu, J Lai, H Zhang, JR White, ... bioRxiv, 2024.02. 27.582096, 2024 | | 2024 |
